Pancreas Cancer Discussion Page:
An Unmoderated Forum
*
 
Support pancreas research*DISCLAIMER: This page is an unmoderated forum, and the opinions expressed herein do not necessarily reflect the viewpoint of The Johns Hopkins Medical Institutions. Patients are advised to consult their personal physicians before making any medical decisions.
FULL DISCLAIMER

Pancreas Cancer

Genetic Testing was posted 03/27/2018 03:40 pm by Dale
E-mail Address:

Message Text
We've begun an intitiative to promote genetic testing on all patients newly diagnosed with ductal adenocarcinoma of the pancreas (pancreatic cancer).

The aim being to identify that subset which may better be treated by regimens including DNA cross-linking agents such as platinum, PARP inhibitors and others - rather than perhaps more standard treatment options.

This sub-type of pancreatic cancer (maybe 15%) is related to germline genetic mutations in the 'homologous recombination DNA repair pathway' involving such genes as BRCA1, BRCA2, PALB2, ATM, RAD51, and others.

There is more on our site at: http://pancreatica.org/genetic-testing-for-pancreatic-cancer/

Best wishes, Dale O'Brien, MD Pancreatica Initiative

Reply to this message | Return to Main Message List


Responses

*DISCLAIMER: This page is an unmoderated forum, and the opinions expressed herein do not necessarily reflect the viewpoint of The Johns Hopkins Medical Institutions. Patients are advised to consult their personal physicians before making any medical decisions.
FULL DISCLAIMER


Pancreas Home | Surgical | Medical | Basic Sci | Docs | Registry | FAQ | Appts | Chat

Feedback | Pathology Home | Oncology Center Home | Search
Copyright © 2020 The Johns Hopkins University, Baltimore, Maryland
Last Modified: 11/11/2002 10:50 am